Deaths associated with MBDB misuse

International Journal of Legal Medicine

Volumn 113, Issue 3, 2000, Pages 168-170

  Carter, N ^a   Rutty, G N ^a   Milroy, C M ^a   Forrest, A R W ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Eden Death; MBDB Ecstasy; N methyl 1 (3,4 methylenedioxyphenyl) 2 butanamine

Indexed keywords

1 (3,4 METHYLENEDIOXYPHENYL) N METHYL 2 BUTAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; PHENETHYLAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; DRUG ABUSE; FEMALE; FORENSIC PATHOLOGY; HUMAN; MALE; PRIORITY JOURNAL; STOMACH CONTENT; TOXICITY TESTING;

3,4-METHYLENEDIOXYAMPHETAMINE; ADULT; AUTOPSY; CAUSE OF DEATH; DANCING; FEMALE; GREAT BRITAIN; HUMANS; MALE; SUBSTANCE-RELATED DISORDERS; SUICIDE;

EID: 0034043601     PISSN: 09379827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004140050291     Document Type: Article

References (31)

1. Saunders N (1997) Ecstasy reconsidered. Nicholas Saunders, London
2. Milroy CM, Clark JC, Forrest ARW (1996) The pathology of deaths associated with "Ecstasy" and "Eve" misuse. J Clin Pathol 49:149-153
3. Kintz P, Giroud C (1997) Immunoassay resonses of MBDB. J Anal Toxicol 21:589-590
4. Shulgin A, Shulgin A (1991) PIHKAL: A chemical love story. Transform Press, Berkeley CA. 1991
5. Dowling GP, McDonough E, Bost R (1987) "Eve" and "ecstasy". A report of five deaths asociated with the use of MDEA and MDMA. JAMA 257:1615-1617
6. Suarez R.V, Riemersma R (1988) "Ecstasy" and sudden cardiac death. Am J Forensic Med Pathol 9:339-341
7. Milroy CM (1999) Ten years of "ecstasy". J R Soc Med 92:68-72
8. Chadwick IS,Curry PD, Linsley A, Freemont AJ, Doran B (1991) Ecstasy, 3,4-methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J R Soc Med 84:371
9. Campkin NT, Daies UM (1992) Another death from "ecstasy". J R Soc Med 85:61
10. Henry JA, Jeffreys KJ, Dawling S (1992) Toxicity and deaths from 3.4-methylenedioxymethamphetamine ("ecstasy"). Lancet 340:384-387
11. Forrest ARW, Galloway JH, Marsh ID, Strachan GA, Clark JC (1994) A fatal overdose with 3,4-methylenedioxymethamphetamine derivatives. Forensic Sci Int 64:57-59
12. Squier MV, Jalloh S, Hilton-Jones D, Series H (1995) Death after ecstasy ingestion:neuropathological findings. J Neurol Neurosurg Psychiatry 58:756-764
13. Dar KJ, McBrien ME (1996) MDMA induced hyperthermia:report of a fatality and review of current therapy. Intensive Care Med 22:995-996
14. Coore JR (1996) A fatal trip with ecstasy:a case of 3,4-methylenemethdioxyamphetamine/3.4-methylenedioxyamphetamine. J R Soc Med 89:51-52
15. Cox DE, Williams KR (1996) "Adam" or "Eve"? - a toxicological conundrum. Forensic Sci Int 77:101-108
16. Fineschi V, Masti A (1996) Fatal poisoning by MDMA (ecstasy) and MDEA:a case report. Int J Legal Med 108:272-275
17. Lora-Tamayo C, Tena T, Rodriguez A (1997) Amphetamine derivative related deaths. Forensic Sci Int 85:149-157
18. Wienman W, Bohnert M (1998) Lethal monointoxication by overdosage of MDEA. Forensic Sci Int 91:91-101
19. Shearman JD, Satsangi J, Chapman RWG, Ryley NG (1992) Misuse of ecstasy. BMJ 305:309
20. Gorard DA, Davies SA, Clark ML (1992) Misuse of ecstasy BMJ 305:309
21. deMan RA, Wilson JH, Tjen HS (1993) Acute liver failure caused by methylenedioxymethamphetamine ("ecstasy"). Ned Tijdschr Geneeskd 137:727-729
22. Dykhuizen RS, Brunt PW, Atkinson P, Simpson JG, Smith CC (1995) Ecstasy induced hepatitis mimiking viral hepatitis. Gut 36:939-941
23. Khakoo SI, Coles CJ, Armstrong JS, Barry RE (1995) Hepatotoxicity and accelerated fibrosis following 3, 4-methylenedioxymetamphetamine ("ecstasy") usage. J Clin Gastroenterol 20:244-247
24. Ellis AJ, Wendon JA, Portmann B, Williams R (1996) Acute liver damage and ecstasy ingestion. Gut 38:454-458
25. Hellinger A, Rauen U, de Groot H, Erhard J (1997) Auxiliary liver transplantation for acute liver failure after intake of 3,4-methylenedioxymethamphetamine ("ecstasy"). Dtsch Med Wochenschr 122:716-720
26. Maxwell DL, Polkey MI, Henry JA (1993) Hyponatraemia and catatonic stupor after taking "ecstasy". BMJ 307:1399
27. Holden R, Jackson MA (1996) Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA). Lancet 347:1052
28. Henry JA, Fallon JK, Kicman AT, Hutt AJ, Cowman DA, Forsling M (1998) Low-dose MDMA ("ecstasy") induces vasopressin secretion. Lancet 351:1784
29. Furnari C, Ottaviano V, Rosati F, Tondi V (1998) Identification of 3,4-methlenedioxyamphetamine analogs encountered in clandestine tablets. Forensic Sci Int 92:49-58
30. Kronstrand R (1996) Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug misusers. J Anal Toxicol 20:512-516
31. Byard RW, Gilbert J, James R, Lokan RJ (1998) Amphetamine derivative deaths in South Australia - Is "Ecstasy" the culprit? Am J Forensic Med Pathol 19:261-265